GlassScriptPhysician profile
Pantea Mozayeni
NPI 1043279722
$1,432.32
in general payments reported to CMS, 2019-2025
22 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $153 · 2021: $62.01 · 2022: $89.10 · 2023: $230 · 2024: $203 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $216.88 | 2022-2025 | |
| Abbvie INC. | $163.03 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $120.89 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $105.48 | 2019-2024 | |
| Therapeuticsmd, INC. | $101.07 | 2019-2020 | |
| Pfizer INC. | $100.52 | 2019-2024 | |
| Avion Pharmaceuticals | $80.25 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $69.98 | 2019-2020 | |
| Allergan, INC. | $66.55 | 2019-2020 | |
| Baxter Healthcare | $61.22 | 2024 | Perclot |
| Coopersurgical, INC. | $61.09 | 2019-2025 | Paragard T 380a |
| Shield Therapeutics INC | $36.47 | 2023 | Accrufer |
| Astellas Pharma US INC | $32.66 | 2023 | Veozah |
| Daiichi Sankyo INC. | $31.22 | 2019 | |
| Ethicon US, LLC | $29.48 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $28.39 | 2019 | |
| Hologic Sales and Service, LLC | $28.29 | 2019 | |
| Lupin INC. | $25.46 | 2019-2020 | |
| Organon LLC | $23.47 | 2021 | |
| Minerva Surgical, INC | $18.75 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.24 | 2019 | |
| Meditrina | $12.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pantea Mozayeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.